Finding 497938 (2023-007)

Material Weakness Repeat Finding
Requirement
B
Questioned Costs
$1
Year
2023
Accepted
2024-09-24

AI Summary

  • Core Issue: The organization lacks proper controls to ensure that only allowable costs are charged to federal awards, leading to questioned costs of approximately $41,300.
  • Impacted Requirements: Costs must be necessary, reasonable, and align with the grant budget; current practices resulted in overbilling and unallowable expenditures.
  • Recommended Follow-Up: Implement comprehensive controls for reviewing and approving costs, and retain a CPA consultant to ensure compliance and accurate reporting.

Finding Text

#2023-007 – Major Federal Award Finding – Allowable Costs – Non-Payroll Nature of Finding: Compliance Finding – Allowable Costs and Material Weakness in Internal Controls Over Compliance This is a partial repeat of prior year finding #2022-008. Criteria/Condition: A non-federal entity may only charge allowable costs incurred by the entity that are necessary and reasonable for the administration of the program and are of a nature in line with the categories allowed in the grant budget. The Organization did not have controls in place to verify that costs were being charged to the award in the correct amount or for necessary and reasonable expenditures. Questioned Costs: Approximately $41,300 Identification of How Questioned Costs Were Computed: A sample of 40 non-payroll expenditures totaling approximately $110,000 was selected from a population of approximately $175,000 of non-payroll expenditures charged to the major program during the year ending December 31, 2023. Of the invoices selected for testing, the following are identified as questioned costs: • 2 expenditures, totaling $5,708, were erroneously billed to the grant twice. Questioned costs are estimated to be approximately $9,000 by projecting this error identified in the sample tested to the population of non-payroll expenditures of the major program. • 2 invoices were billed to the grant at amounts higher than the supporting invoice, totaling $426 overbilled to the grant. Questioned costs are estimated to be approximately $700 by projecting this error identified in the sample tested to the population of non-payroll expenditures of the major program. • 5 expenditures totaling $5,868 were charged to the grant for costs relating to marketing purchases, including branded merchandise, branded apparel, etc. The Organization indicated these items were purchased with the primary intent to distribute during the National Alliance of Recovery Residences (NARR) annual conference. Though certain costs related to this conference were allowed under the grant budget, marketing costs were not included, and therefore appear to be unallowable. Questioned costs are estimated to be approximately $9,400 by projecting this error identified in the sample tested to the population of non-payroll expenditures of the major program. • Questioned costs were identified for costs relating to the lease of a second space. Costs totaling up to $12,000 were allocated in part to the major program as office lease expenditures but were instead described to be an employee fringe benefit. These costs were determined to be outside of those necessary and reasonable for the administration of the program. • 3 expenditures were charged to the grant for costs that were at least partially not necessary and reasonable or otherwise appear to be unallowable. Questioned costs are estimated to be approximately $10,200 by projecting this error identified in the sample tested to the population of non-payroll expenditures of the major program. Cause/Context: There are not proper controls in place to review invoices and ensure grant billings are in line with allowable costs incurred. Further, a portion of lease costs appear to be classified inconsistent with the underlying nature of the space. Effect: An overstatement of expenditures for the grant was reported and submitted for reimbursement. Recommendation: We recommend that a full-range of controls over costs charged to federal programs be implemented. The Organization should devote the resources necessary to ensure that such costs are allowable, of direct benefit to the program, are reviewed, approved, documented, and that the accounting and reporting process is accurate. Further, controls over grant billings should be established to ensure expenditures represent actual costs incurred. All control activities, including independent review should be documented and evidence of review and approval be maintained. Views of Responsible Officials and Planned Corrective Actions: MARR will retain a CPA consultant to implement a full range of controls over costs charged to federal programs. MARR’s protocol shall ensure that such costs are the direct benefit to the program, are reviewed, approved, documented and ensure the accounting and reporting process be accurate. Further, controls over grant billings will be established to ensure expenditures represent actual costs incurred. All control activities, including independent review, should be documented and evidence of review and approval will be maintained.

Corrective Action Plan

Planned Corrective Actions: MARR will retain a CPA consultant to implement a full - range of controls relating to reporting, including federal program reporting. MARR will take such steps as necessary to ensure that reports are timely and accurately prepared, reviewed, and approved prior to filing. All controls, including review and approval will be documented in such documentation to be maintained. MARR will retain a CPA consultant to implement and adopt formal written policies relating to grants management ordered by Uniform Guidance.

Categories

Questioned Costs Allowable Costs / Cost Principles Procurement, Suspension & Debarment Cash Management Material Weakness Reporting Matching / Level of Effort / Earmarking

Other Findings in this Audit

  • 497935 2023-004
    Material Weakness Repeat
  • 497936 2023-005
    Material Weakness Repeat
  • 497937 2023-006
    Material Weakness Repeat
  • 497939 2023-008
    Material Weakness Repeat
  • 497940 2023-009
    Material Weakness Repeat
  • 497941 2023-010
    Material Weakness Repeat
  • 497942 2023-004
    Material Weakness Repeat
  • 497943 2023-005
    Material Weakness Repeat
  • 497944 2023-006
    Material Weakness Repeat
  • 497945 2023-007
    Material Weakness Repeat
  • 497946 2023-008
    Material Weakness Repeat
  • 497947 2023-009
    Material Weakness Repeat
  • 497948 2023-010
    Material Weakness Repeat
  • 1074377 2023-004
    Material Weakness Repeat
  • 1074378 2023-005
    Material Weakness Repeat
  • 1074379 2023-006
    Material Weakness Repeat
  • 1074380 2023-007
    Material Weakness Repeat
  • 1074381 2023-008
    Material Weakness Repeat
  • 1074382 2023-009
    Material Weakness Repeat
  • 1074383 2023-010
    Material Weakness Repeat
  • 1074384 2023-004
    Material Weakness Repeat
  • 1074385 2023-005
    Material Weakness Repeat
  • 1074386 2023-006
    Material Weakness Repeat
  • 1074387 2023-007
    Material Weakness Repeat
  • 1074388 2023-008
    Material Weakness Repeat
  • 1074389 2023-009
    Material Weakness Repeat
  • 1074390 2023-010
    Material Weakness Repeat

Programs in Audit

ALN Program Name Expenditures
93.788 Opioid Str $117,344
93.959 Block Grants for Prevention and Treatment of Substance Abuse $35,139